Author | Lynda Charters


Study evaluates periodic aflibercept injections in NPDR treatment

The proportion of eyes that developed PDR or centre-involving DMO was lower with periodic aflibercept treatments compared with sham treatment through the 2-year point.

Dropless glaucoma treatment: An elusive path to ease burden

Ophthalmologists should consider numerous options for treating individual glaucoma patients, including non-medical interventions.

Shedding light on Horner’s syndrome

Investigators found that 56.4% of Horner’s syndrome cases resulted from a dangerous cause.